Buscar
Mostrando ítems 1-10 de 38
Biopharmaceutics drug disposition classification system
(Springer Nature Switzerland AG, 2021)
The Biopharmaceutics Drug Disposition Classification System (BDDCS) is a revision of the Biopharmaceutics (or Biopharmaceutical) Classification System (BCS) that may be useful to predict routes of elimination and to foresee ...
Comparative oral drug classification systems: Acetazolamide, azithromycin, clopidogrel, and efavirenz case studies
(American Chemical Society, 2018-08)
Biopharmaceutics classification systems based on the properties of solubility and permeability or the extension of metabolism are very important tools in the early stages of the development and regulatory stages of new ...
Provisional Biopharmaceutical Classification of Some Common Herbs Used in Western Medicine
(AMER CHEMICAL SOCWASHINGTON, 2012)
The aim of this study was to classify some markers of common herbs used in Western medicine according to the Biopharmaceutical Classification System (BCS). The BCS is a scientific approach to classify drug substances based ...
Evaluation of pantoprazole formulations in different dissolution apparatus using biorelevant medium
(Ecv-editio Cantor Verlag Medizin NaturwissenschaftenAulendorfAlemanha, 2010)
Intrinsic Dissolution as a Tool for Evaluating Drug Solubility in Accordance with the Biopharmaceutics Classification System
(DISSOLUTION TECHNOLOGIES, INC, 2011)
The Biopharmaceutics Classification System (BCS) is a tool that was created to categorize drugs into different groups according to their solubility and permeability characteristics. Through a combination of these factors ...
Biowaiver monographs for immediate-release solid oral dosage forms: Stavudine
(WILEY-BLACKWELLMALDEN, 2012)
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate-release (IR) solid oral dosage forms containing stavudine (d4T) are reviewed. According to ...
Biowaiver monographs for immediate release solid oral dosage forms: Ciprofloxacin hydrochloride
(John Wiley & Sons Inc, 2011-01)
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of new multisource and reformulated immediate release (IR) solid oral dosage forms containing ciprofloxacin ...